The effect of postmenopausal estrogen therapy on the risk of non- insulin-dependent diabetes mellitus

L.L. Gabal, D. Goodman-Gruen and E. Barrett-Connor

American Journal of Public Health, 1997, vol. 87, issue 3, 443-445

Abstract: Objectives. This study examined the effect of postmenopausal estrogen replacement therapy on the incidence of non-insulin-dependent diabetes in women. Methods. Postmenopausal women aged 50 through 70 years (n = 848) without diagnosed diabetes at baseline were followed for 10 to 15 years for incident diabetes. Results. Over the average 11.5 year follow-up, there were 105 new cases of diabetes. The age-adjusted relative-risk for development of diabetes was nonsignificantly lower for women with continuous estrogen replacement therapy use than for never users. After adjustment for major covariates, a nonsignificant linear trend with increasing duration of estrogen replacement therapy was reversed. Conclusions. This study suggests that previous results showing a reduced risk of diabetes in women using estrogen may have been due to selection bias regarding who is prescribed estrogen, confounding factors, or differential diagnostic efforts.

Date: 1997
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:aph:ajpbhl:1997:87:3:443-445_7

Access Statistics for this article

American Journal of Public Health is currently edited by Alfredo Morabia

More articles in American Journal of Public Health from American Public Health Association
Bibliographic data for series maintained by Christopher F Baum ().